AHPPI Winter Meeting 2010

AHPPI Winter Meeting 2010 - Biographies

Professor David JM Lewis, MD

Qualified in Medicine University of Wales 1983, postgraduate medical education in General (Internal) Medicine in S Wales, followed by training in microbiology at London School of Hygiene & Tropical Medicine, and Infectious Diseases at St George's, Tooting. In 1988, Professor Lewis took up position at St George's to carry out research on mucosal immunology, vaccines and HIV. He was appointed Consultant Physician in 1994, and Professor of Clinical Vaccinology & Medicine in 2006.

Professor Lewis specialises in translational immunology and vaccine studies, especially mucosal vaccines; genetically modified live organisms; and vaccines against TB, HIV and enteric infections.

Professor John Oxford

Professor John Oxford is Scientific Director and founder of Retroscreen Virology Ltd and Professor of Virology at St Bartholomew’s and the Royal London Hospital, Queen Mary’s School of Medicine and Dentistry. He has co-authored two standard texts: ‘Influenza, the Viruses and the Disease' with Sir Charles Stuart-Harris and G.C. Schild and most recently, "Human Virology, a Text for Students of Medicine, Dentistry and Microbiology", published by Oxford University Press. Professor Oxford has also published 250 scientific papers.

Dr Afshan Ahmed, PhD

Presently the Director of Research and Development for Vaccine Research International Plc which was set up to carry out a Phase I Clinical Trial of a Staphylococcus aureus vaccine and has been her area of interest and research for many years. Dr Ahmed was involved in the formation of the company and she is one of the key figures in its day to day running and future planning.

Her research career has involved work mainly in the development of a Staphylococcal vaccine and application of that method to vaccines against other organisms for example Streptococci and Dermatophilus. Dr Ahmed has been involved in patenting, grant writing and fundraising to obtain funding for research and has presented various research areas at national and international conferences.

Dr Simon A Beddows, PhD

Completed his BSc (Hons) at Manchester Metropolitan University in 1989. He took up a position as a Research Assistant for Imperial College, London where he went on to complete postgraduate medical education in 1998. He was then appointed Post-doctoral Scientist in 1999 and was later appointed Senior Post-doctoral Scientist for Weill Medical College of Cornell University, New York in 2001.
Dr Beddows then took up the role of HPV R&D Section Head for the Centre for Infections, Health Protection Agency in London since 2005.
Simon specialises in HIV-1; HIV Envelope Protein gp120; HIV Antibodies; Neutralization Tests; env Gene Products and HIV Infections.

Professor Geoff Hale PhD, MD of BioPharma Services Europe, BioAnaLab Limited, Oxford, UK

Trained as a Biochemist at the University of Cambridge. In 1980 he joined Herman Waldmann to research therapeutic monoclonal antibodies. In 1995, Herman and Geoff moved to the University of Oxford and set up a centre to manufacture monoclonal antibodies for clinical trials. The Therapeutic Antibody Centre supplied more than 25 different antibodies for trials in over 5000 patients worldwide. In December 2002 he founded BioAnaLab based in Oxford. BioAnaLab specialises in the analysis of biologics including antibodies, vaccines, cytokines and growth factors. In 2009 BioAnaLab was acquired by Millipore and Geoff is now the Managing Director of Millipore’s BioPharma Services in Europe.

Go Back to the Meeting Agenda | Click here to register

	AHPPI St George’s Healthcare Trust Richmond Pharmacology	AHPPI Winter Meeting 2010 - Biographies Professor David JM Lewis, MD Qualified in Medicine University of Wales 1983, postgraduate medical education in General (Internal) Medicine in S Wales, followed by training in microbiology at London School of Hygiene & Tropical Medicine, and Infectious Diseases at St George's, Tooting. In 1988, Professor Lewis took up position at St George's to carry out research on mucosal immunology, vaccines and HIV. He was appointed Consultant Physician in 1994, and Professor of Clinical Vaccinology & Medicine in 2006. Professor Lewis specialises in translational immunology and vaccine studies, especially mucosal vaccines; genetically modified live organisms; and vaccines against TB, HIV and enteric infections. Professor John Oxford Professor John Oxford is Scientific Director and founder of Retroscreen Virology Ltd and Professor of Virology at St Bartholomew’s and the Royal London Hospital, Queen Mary’s School of Medicine and Dentistry. He has co-authored two standard texts: ‘Influenza, the Viruses and the Disease' with Sir Charles Stuart-Harris and G.C. Schild and most recently, "Human Virology, a Text for Students of Medicine, Dentistry and Microbiology", published by Oxford University Press. Professor Oxford has also published 250 scientific papers. Dr Afshan Ahmed, PhD Presently the Director of Research and Development for Vaccine Research International Plc which was set up to carry out a Phase I Clinical Trial of a Staphylococcus aureus vaccine and has been her area of interest and research for many years. Dr Ahmed was involved in the formation of the company and she is one of the key figures in its day to day running and future planning. Her research career has involved work mainly in the development of a Staphylococcal vaccine and application of that method to vaccines against other organisms for example Streptococci and Dermatophilus. Dr Ahmed has been involved in patenting, grant writing and fundraising to obtain funding for research and has presented various research areas at national and international conferences. Dr Simon A Beddows, PhD Completed his BSc (Hons) at Manchester Metropolitan University in 1989. He took up a position as a Research Assistant for Imperial College, London where he went on to complete postgraduate medical education in 1998. He was then appointed Post-doctoral Scientist in 1999 and was later appointed Senior Post-doctoral Scientist for Weill Medical College of Cornell University, New York in 2001. Dr Beddows then took up the role of HPV R&D Section Head for the Centre for Infections, Health Protection Agency in London since 2005. Simon specialises in HIV-1; HIV Envelope Protein gp120; HIV Antibodies; Neutralization Tests; env Gene Products and HIV Infections. Professor Geoff Hale PhD, MD of BioPharma Services Europe, BioAnaLab Limited, Oxford, UK Trained as a Biochemist at the University of Cambridge. In 1980 he joined Herman Waldmann to research therapeutic monoclonal antibodies. In 1995, Herman and Geoff moved to the University of Oxford and set up a centre to manufacture monoclonal antibodies for clinical trials. The Therapeutic Antibody Centre supplied more than 25 different antibodies for trials in over 5000 patients worldwide. In December 2002 he founded BioAnaLab based in Oxford. BioAnaLab specialises in the analysis of biologics including antibodies, vaccines, cytokines and growth factors. In 2009 BioAnaLab was acquired by Millipore and Geoff is now the Managing Director of Millipore’s BioPharma Services in Europe. Go Back to the Meeting Agenda \| Click here to register